BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Short Report
Year : 2026  |  Volume : 17  |  Issue : 4  |  Page : 8891-8892 Full Version
A review: python-driven collaboration and data automation in clinical trials
Int J Biol Med Res. 2026; 17(4): 8891-8892  |  DOI: 10.65048/ijbmr.2026.17.4.8891.1108
Amit Vilasrao Pondkule*
Dept of Pharmaceutics, Dattakala College of Phramacy,swami-Chincholi,Daund
Correspondence Address :
Mr. Amit Vilasrao Pondkule,
Dept of Pharmaceutics
Dattakala College of Phramacy,swami-Chincholi,Daund E-mail: pondkulemit@gmail.com
Received: May 9, 2026 Accepted: July 30, 2026 Published: October 3, 2026

Abstract
Clinical trials are fundamental to advancing medical science, requiring efficient collaboration among multidisciplinary study teams and robust data management systems. With the growing complexity and volume of clinical data, traditional tools often fall short in ensuring efficiency, scalability, and accuracy. This review paper examines the role of the Python programming language as a transformative tool in clinical trial workflows. Python’s extensive ecosystem supports data extraction from PDFs, advanced analytics through artificial intelligence (AI) and machine learning (ML), and automation of reporting processes such as dynamic Word document updates. These capabilities enhance data handling, enable predictive insights, and improve communication among stakeholders. Synthesizes existing approaches and tools, highlights the advantages and limitations of Python in regulated environments, and discusses its potential to improve clinical trial efficiency and patient outcomes.
Keywords
Data management, Clinical Trials and data, Python programming, Artificial intelligence, Patient outcomes

References

[1] Zango ZU, Lawal MA, Usman F, Sulieman A, Akhdar H, Eisa MH, Aldaghri O, Ibnaouf KH, Lim JW, Khoo KS, Cheng YW. Promoting the suitability of graphitic carbon nitride and metal oxide nanoparticles: A review of sulfonamides photocatalytic degradation. Chemosphere. 2024 Mar;351:141218. doi: 10.1016/j.chemosphere.2024.141218. Epub 2024 Jan 22. PMID: 38266876.
[2] Serrano-Arias B, Araya-Zúñiga A, Waterhouse-Garbanzo J, Rojas-Barrantes Z, Arguedas-Chacón S, Zavaleta-Monestel E. A Comprehensive Review of Sulfonamide Hypersensitivity: Implications for Clinical Practice. Clin Rev Allergy Immunol. 2023 Dec;65(3):433-442. doi: 10.1007/s12016-023-08978-w. Epub 2024 Jan 4. PMID: 38175321.
[3] Cao L. et al. Optimization and performance evaluation of a fluorescent sensor for residual sulfonamide antibiotics in honey samples. Polym. Adv. Technol.2024; 35(3), e6351.
[4] Alani B G, Salim K S, Mahdi A S,  Al-Temimi A A. Sulfonamide derivatives: Synthesis and applications. Int. J. Front. Chem. Pharm. Res. 2024;4, 1–15.
[5] Bücker M, Hoti K,  Rose O. Artificial  intelligence to assist decision-making on pharmacotherapy: A feasibility study. Exploratory Research in Clinical and Social Pharmacy,2024; 15: 100491. 
[6] Chalasani S, Syed J, Madhan R, Patil V,  Kumar T. Artificial intelligence in the field of pharmacy practice: A literature review. Exploratory Research in Clinical and Social Pharmacy,2023; 12: 100346. 
[7] Jarab A S, Abu Heshmeh, S R,  Al Meslamani A Z. Artificial intelligence (AI) in pharmacy: An overview of innovations. Journal of Medical Economics, 2023;26(1): 1261–1265.


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications